Skip to content

Cervical Cancer Screening Strategies

A Retrospective Cohort Study on the Effectiveness of Various Screening Strategies for Uterine Cervical Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05309122
Enrollment
10000
Registered
2022-04-04
Start date
2022-03-19
Completion date
2025-03-19
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Screening, Cervical Cancer, Cervical Cytology, Cervical Intraepithelial Neoplasia, Human Papillomavirus Infection

Brief summary

This study is to investigate retrospectively the results of cervical cytology and high-risk human papillomavirus in the past 20 years recorded in Peking Union Medical College Hospital. The histological findings after cervical cancer screening were reviewed. The diagnostic values of different screening strategies were compared based on the results of cervical histology. The primary endpoint is the diagnosis of grade 2 cervical intraepithelial neoplasia (CIN2) or more severe lesions (CIN2+). The secondary endpoints include following objectives: (1) the invasive procedures needed according to the screening results; (2) the diagnosis of vaginal and/or vulval intraepithelial neoplasia; (3) the persistence and recurrence of human papillomavirus infection; and (4) the cost-effectiveness of screening strategies for CIN2+.

Interventions

None listed

Sponsors

Lei Li
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 18 years or older * With definite cervical histology after cervical cancer screening, ore with at least one screening test after first testing

Exclusion criteria

\- Not meeting all of the inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
CIN2+One yearCIN2+ detected by various screening methods

Secondary

MeasureTime frameDescription
Invasive proceduresOne yearInvasive procedures needed according to the screening results
Vaginal intraepithelial neoplasia (VaIN)One yearVaIN detected by various screening methods
Vulval intraepithelial neoplasia (VIN)One yearVIN detected by various screening methods

Countries

China

Contacts

Primary ContactLei Li, M.D.
lileigh@163.com86-139-1198-8831

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026